Literature DB >> 1795160

Tamoxifen fails to block estradiol accumulation, yet is weakly accumulated by the juvenile zebra finch anterior hypothalamus: an autoradiographic study.

G A Mathews1, A P Arnold.   

Abstract

In experiment 1, we used autoradiographic procedures to examine whether tamoxifen could displace 3H-estradiol labeling in the anterior hypothalamus and the caudal nucleus of the ventral hyperstriatum (HVc) of ovariectomized 20-day-old female zebra finches. There was no significant reduction in labeling of cells by 3H-estradiol in birds preinjected with unlabeled tamoxifen. In experiment 2, we found that injections of 3H-tamoxifen caused-weak labeling of cells in the anterior hypothalamus of 20-day-old male and female zebra finches. These results are compatible with the idea that tamoxifen does not block the action of estradiol in the brain of zebra finches, and suggest that the effects of early tamoxifen treatment on the morphology of the song system may reflect central actions of tamoxifen.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1795160     DOI: 10.1002/neu.480220908

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  3 in total

1.  The effects of estradiol on 17β-hydroxysteroid dehydrogenase type IV and androgen receptor expression in the developing zebra finch song system.

Authors:  J Bayley Thompson; Eldin Dzubur; Juli Wade; Michelle Tomaszycki
Journal:  Brain Res       Date:  2011-05-23       Impact factor: 3.252

2.  Overlapping and divergent actions of estrogen and the neurotrophins on cell fate and p53-dependent signal transduction in conditionally immortalized cerebral cortical neuroblasts.

Authors:  S B Wade; P Oommen; W C Conner; D J Earnest; R C Miranda
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

3.  17β-estradiol regulates the sexually dimorphic expression of BDNF and TrkB proteins in the song system of juvenile zebra finches.

Authors:  Yu Ping Tang; Juli Wade
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.